139 related articles for article (PubMed ID: 20497102)
1. Evaluation of the Combined Therapy of DA-7218, a New Oxazolidinone, and Trimethoprim/ Sulfamethoxazole in the Treatment of Experimental Actinomycetoma by Nocardia brasiliensis.
Espinoza-Gonzalez NA; Welsh O; Ocampo-Candiani J; Said-Fernandez S; Lozano-Garza G; Choi SH; Vera-Cabrera L
Curr Drug Deliv; 2010 Jul; 7(3):225-9. PubMed ID: 20497102
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of DA-7218, a new oxazolidinone prodrug, in the treatment of experimental actinomycetoma produced by Nocardia brasiliensis.
Espinoza-González NA; Welsh O; de Torres NW; Cavazos-Rocha N; Ocampo-Candiani J; Said-Fernandez S; Lozano-Garza G; Choi SH; Vera-Cabrera L
Molecules; 2008 Jan; 13(1):31-40. PubMed ID: 18259127
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis.
Vera-Cabrera L; Gómez-Flores A; Escalante-Fuentes WG; Welsh O
Antimicrob Agents Chemother; 2001 Dec; 45(12):3629-30. PubMed ID: 11709356
[TBL] [Abstract][Full Text] [Related]
4. Activity of novel oxazolidinones against Nocardia brasiliensis growing within THP-1 macrophages.
Vera-Cabrera L; Espinoza-González NA; Welsh O; Ocampo-Candiani J; Castro-Garza J
J Antimicrob Chemother; 2009 Nov; 64(5):1013-7. PubMed ID: 19710075
[TBL] [Abstract][Full Text] [Related]
5.
Brown-Elliott BA; Wallace RJ
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923878
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis.
Vera-Cabrera L; Gonzalez E; Rendon A; Ocampo-Candiani J; Welsh O; Velazquez-Moreno VM; Choi SH; Molina-Torres C
Antimicrob Agents Chemother; 2006 Sep; 50(9):3170-2. PubMed ID: 16940121
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of ciprofloxacin and moxifloxacin against Nocardia brasiliensis in vitro and in an experimental model of actinomycetoma in BALB/c mice.
Chacon-Moreno BE; Welsh O; Cavazos-Rocha N; de la Luz Salazar-Cavazos M; Garza-Lozano HG; Said-Fernandez S; Ocampo-Candiani J; Vera-Cabrera L
Antimicrob Agents Chemother; 2009 Jan; 53(1):295-7. PubMed ID: 18852277
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic Nocardia cyriacigeorgica and Nocardia nova Evolve To Resist Trimethoprim-Sulfamethoxazole by both Expected and Unexpected Pathways.
Mehta H; Weng J; Prater A; Elworth RAL; Han X; Shamoo Y
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686152
[No Abstract] [Full Text] [Related]
9. Antimicrobial susceptibility profiles and species distribution of medically relevant Nocardia species: Results from a large tertiary laboratory in Australia.
Tan YE; Chen SC; Halliday CL
J Glob Antimicrob Resist; 2020 Mar; 20():110-117. PubMed ID: 31400449
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Activity of the Benzothiazinones PBTZ169 and BTZ043 against Nocardia brasiliensis.
González-Martínez NA; Lozano-Garza HG; Castro-Garza J; De Osio-Cortez A; Vargas-Villarreal J; Cavazos-Rocha N; Ocampo-Candiani J; Makarov V; Cole ST; Vera-Cabrera L
PLoS Negl Trop Dis; 2015; 9(10):e0004022. PubMed ID: 26474057
[TBL] [Abstract][Full Text] [Related]
11. In vivo therapeutic effect of gatifloxacin on BALB/c mice infected with Nocardia brasiliensis.
Daw-Garza A; Welsh O; Said-Fernández S; Lozano-Garza HG; Waksman de Torres N; Rocha NC; Ocampo-Candiani J; Vera-Cabrera L
Antimicrob Agents Chemother; 2008 Apr; 52(4):1549-50. PubMed ID: 18285484
[TBL] [Abstract][Full Text] [Related]
12. Case report: Actinomycetoma caused by Nocardia aobensis from Lao PDR with favourable outcome after short-term antibiotic treatment.
Vongphoumy I; Dance DA; Dittrich S; Logan J; Davong V; Rattanavong S; Blessmann J
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003729. PubMed ID: 25879445
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain.
Valdezate S; Garrido N; Carrasco G; Medina-Pascual MJ; Villalón P; Navarro AM; Saéz-Nieto JA
J Antimicrob Chemother; 2017 Mar; 72(3):754-761. PubMed ID: 27999029
[TBL] [Abstract][Full Text] [Related]
14. Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey.
Brown-Elliott BA; Biehle J; Conville PS; Cohen S; Saubolle M; Sussland D; Wengenack N; Kriel K; Bridge L; McNulty S; Vasireddy R; Wallace RJ
J Clin Microbiol; 2012 Mar; 50(3):670-2. PubMed ID: 22170936
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of a novel oxazolidinone, DA-7867, in BALB/c mice infected with Nocardia brasiliensis.
Vera-Cabrera L; Daw-Garza A; Said-Fernández S; Lozano-Garza HG; de Torres NW; Rocha NC; Ocampo-Candiani J; Choi SH; Welsh O
PLoS Negl Trop Dis; 2008 Sep; 2(9):e289. PubMed ID: 18820738
[TBL] [Abstract][Full Text] [Related]
16. Retrospective Analysis of Antimicrobial Susceptibility Profiles of
Hamdi AM; Fida M; Deml SM; Abu Saleh OM; Wengenack NL
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818815
[No Abstract] [Full Text] [Related]
17. Actinomycetoma and advances in its treatment.
Welsh O; Vera-Cabrera L; Welsh E; Salinas MC
Clin Dermatol; 2012; 30(4):372-81. PubMed ID: 22682184
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility profiles of Nocardia isolates based on current taxonomy.
Schlaberg R; Fisher MA; Hanson KE
Antimicrob Agents Chemother; 2014; 58(2):795-800. PubMed ID: 24247124
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis.
Gomez-Flores A; Welsh O; Said-Fernández S; Lozano-Garza G; Tavarez-Alejandro RE; Vera-Cabrera L
Antimicrob Agents Chemother; 2004 Mar; 48(3):832-7. PubMed ID: 14982772
[TBL] [Abstract][Full Text] [Related]
20. Systemic increased immune response to Nocardia brasiliensis co-exists with local immunosuppressive microenvironment.
Salinas-Carmona MC; Rosas-Taraco AG; Welsh O
Antonie Van Leeuwenhoek; 2012 Oct; 102(3):473-80. PubMed ID: 22825801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
